Search This Blog

Wednesday, September 19, 2018

Merck cuts key cancer drug price for China launch, Caixin reports


Merck (MRK) will cut the price of one of its core cancer drugs in half for its China launch following a similar move by competitor Bristol-Myers Squibb (BMY), Caixin Global reports
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)